Hold COF at benchmark weight; await Tier 1 ($204-214) or Tier 2 ($231+) entry with ≤50% sizing cap
Hold at $221.45 given unconfirmed 50/200 SMA death cross resolution, 9.03% ROE below the 12-15% historical range, and a ~25% gap between consensus forward EPS ($24.05) and Q2 2026 annualized run-rate ($19). The valuation appears anomalous (forward P/E 9.21x, PEG 0.24-0.37, 33% projected EPS growth) with real fundamental support ($8B quarterly FCF, Q1 2026 EPS $4.73, buyback acceleration from $667M to $2.75B/quarter, NII expansion $31.2B to $42.9B), but goodwill/intangible risk ($48B, 42% of equity), credit deterioration tail risk, and the hawkish Fed macro headwind justify disciplined sizing capped at ≤50% normal starter. Do not force-fit entry triggers; trim to benchmark if currently overweight rather than passively carrying overweight through uncertain timing.
| Position | Action |
|---|---|
| Price in Tier 1 entry zone ($204-214) with death cross resolution | ≤50% of normal starter position |
| Confirmed close above $231 on volume ≥3M shares (Tier 2) | ≤50% of normal starter position |
| Currently overweight | Trim to benchmark weight |
| Existing holders with overweight position | Trim to benchmark to avoid compounding entry-timing error into sizing error |
Capital One's Discover merger has created a structurally superior franchise with a 0.24 PEG, 33% forward earnings growth, and single-digit forward P/E that the market is mispricing as uncertainty rather than the transformational rerating it represents.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 60.20 | bullish |
| MACD | 5.58 | neutral |
| MACD Signal | 5.16 | neutral |
| MACD Histogram | 0.42 | neutral |
| ATR (14) | 5.11 | neutral |
| Bollinger Upper Band | 230.99 | neutral |
| Bollinger Lower Band | 198.00 | neutral |
| Bollinger Mid (20-SMA) | 214.49 | neutral |
| 10-EMA | 220.48 | bullish |
| 50-SMA | 204.88 | bullish |
| 200-SMA | 206.63 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed daily close above $231 on volume ≥3M shares
Then: Initiate ≤50% normal starter
↩ rebuts: “Bear's focus on Q1 2025 $4.28B net loss is a one-time M&A charge, not current fundamentals”
· concedes: The 19.6% gain in 90 days does represent some immediate re-rating already occurring; The 'death cross' technical pattern is technically present, though resolving; Berkshire's trim does represent some selling pressure, even if not COF-specific
COF is a conditional value stock, not an obvious mispricing. The bear does not need COF to fail; the bear only needs one of the bull's assumptions (Discover synergies, credit quality, funding costs, or earnings durability) to disappoint.
· concedes: COF's buybacks accelerated and long-term debt declined by approximately $6.6B in Q2 2026, which are constructive capital allocation actions; COF's 2025 net interest income increased despite the rate environment; Price is above major moving averages and MACD has not turned bearish; Low volume means there was no capitulation; The reported equity-to-assets ratio of 16.9% is supportive of balance sheet strength; The bull's Discover synergy timeline may be correct, and 2025 may indeed represent a merger trough
→ vs conservative: PEG of 0.24 is not 'suspicious' but a screaming signal of mispricing; waiting for 'proof of accretion' guarantees paying a higher price
→ vs conservative: Credit cycle risk is real but distant; Q1 2026 loan book healthy at $434.5B; 6-9 month runway before it becomes dominant narrative
→ vs conservative: Hawkish Fed is a tailwind for COF's NIM, not a headwind, as deposit costs have normalized and asset yields remain elevated
→ vs neutral: Waiting for pullback to $204-$214 risks missing the move; 50 SMA racing upward and buybacks/institutional flow make $204 revisit unlikely
→ vs neutral: Death cross concern is overblown; fast-moving 50 SMA rising aggressively toward flat 200 SMA resolves within weeks, not months
→ vs neutral: Current stock 8.1% above 50 SMA means waiting for technical confirmation means buying after significant upside already occurred
| neutral |
Support: 220.48 · 214.49 · 204.88 · 198 | Resistance: 227.34 · 230.99 · 241 · 246
COF staged a clean recovery from the July 199.96 low to 227.34, but the August 17 reversal candle (221.45 close, down 2.59% intraday) combined with shrinking MACD histogram, RSI cooling from 70.22, and low volume (1.78M vs 3.84M breakout volume) signals momentum is pausing rather than advancing. The medium-term structure shows the 50 SMA (204.88) below the 200 SMA (206.63), preventing unambiguous bullish confirmation. Recommend HOLD with tactical positioning: tighten stops to 10 EMA (220.48) or 20 SMA (214.49), enter new longs on successful retest of 214–216, and monitor 227.34 rejection for short opportunities.
Market Cap
$135.86B
Trailing P/E
12.21x
Forward P/E
9.21x
PEG Ratio
0.24
Price/Book
1.32x
EV/Revenue (TTM)
~2.8x
Dividend Yield
1.41%
Beta
1.016
Profit Margin
21.87%
Operating Margin
33.63%
Return on Equity (ROE)
9.03%
Return on Assets (ROA)
1.52%
EPS (TTM)
$18.14
Forward EPS
$24.05
Net Income (TTM)
$9.82B
Revenue (TTM)
$48.11B
Book Value
$167.86
Diluted Shares
613.5M
Net Interest Income FY2024
$31.21B
Net Interest Income FY2025
$42.88B
Total Revenue FY2022
$34.25B
Total Revenue FY2023
$36.79B
Total Revenue FY2024
$39.11B
Total Revenue FY2025
$53.43B
Net Income FY2022
$7.36B
Net Income FY2023
$4.87B
Net Income FY2024
$4.75B
Net Income FY2025
$2.45B
Diluted EPS FY2022
$17.91
Diluted EPS FY2023
$11.95
Diluted EPS FY2024
$11.59
Diluted EPS FY2025
$4.03
Total Assets FY2024
$490B
Total Assets FY2025
$669B
Net Loans FY2024
$312B
Net Loans FY2025
$431B
Stockholders' Equity FY2024
$60.8B
Stockholders' Equity FY2025
$113.6B
Goodwill FY2024
$15.1B
Goodwill FY2025
$28.5B
Other Intangibles FY2024
$233M
Other Intangibles FY2025
$16.6B
Q1 2025 Revenue
$12.49B
Q1 2025 Net Income
$-4.28B
Q1 2025 Diluted EPS
($8.58)
Q1 2025 Pretax Income
($5.93B)
Q2 2025 Revenue
$15.46B
Q2 2025 Net Income
$3.19B
Q2 2025 Diluted EPS
$4.83
Q2 2025 Pretax Income
$4.38B
Q3 2025 Revenue
$15.39B
Q3 2025 Net Income
$2.13B
Q3 2025 Diluted EPS
$3.26
Q3 2025 Pretax Income
$2.10B
Q4 2025 Revenue
$15.23B
Q4 2025 Net Income
$2.17B
Q4 2025 Diluted EPS
$3.34
Q4 2025 Pretax Income
$2.70B
Q1 2026 Revenue
$15.85B
Q1 2026 Net Income
$3.02B
Q1 2026 Diluted EPS
$4.73
Q1 2026 Pretax Income
$3.82B
Total Assets Q2 2026
$673.8B
Net Loans Q2 2026
$434.5B
Cash & Equivalents Q2 2026
$54.7B
AFS Securities Q2 2026
$88.0B
Total Debt Q2 2026
$44.7B
Stockholders' Equity Q2 2026
$113.8B
Tangible Book Value Q2 2026
$65.9B
Goodwill + Intangibles Q2 2026
$47.9B
Total Liabilities Q2 2026
$560.0B
Equity/Assets
16.9%
Q2 2026 Operating Cash Flow
$8.44B
Q2 2026 Free Cash Flow
$8.08B
Q2 2026 Capex
($0.37B)
Q2 2026 Share Repurchases
($2.75B)
Q2 2026 Dividends Paid
($0.57B)
Q2 2026 Debt Repaid
($6.78B)
Q1 2026 Operating Cash Flow
$6.02B
Q1 2026 Free Cash Flow
$5.47B
Q1 2026 Share Repurchases
($2.79B)
Cumulative Buybacks (Last 5 Quarters)
~$9.8B
52-Week High
$259.64
52-Week Low
$174.24
50-Day Moving Average
$204.11
200-Day Moving Average
$207.63
Current Price (Implied)
~$221.42
Revenue Growth FY24→FY25
+36.6%
Share Count Increase
64%
Strengths
Concerns
Capital One's transformative 2025 acquisition of Discover Financial Services nearly doubled the company's asset base (Assets: $490B→$669B, Loans: $312B→$431B) while creating substantial near-term earnings dilution (2025 EPS: $4.03 vs. $11.59 in 2024) and depressing ROE to 9.03% from historical 12-15% levels. The stock presents an exceptional value opportunity with a PEG of 0.24 and forward P/E of 9.21x, while quarterly earnings have recovered steadily from a Q1 2025 trough loss to Q1 2026 EPS of $4.73. Aggressive share buybacks of $2.75B in Q2 2026 (vs. $0.67B in Q2 2025) and strong FCF generation of $8.08B support ongoing per-share accretion. HOLD recommended as integration matures toward ~2027 when synergies should be fully realized and ROE rebuilds.
Macro: Risk-off macro environment with bond markets under pressure. 30-year Treasury yield at 19-year highs driven by oil and Treasury supply. Fed pricing is hawkish (Polymarket: 85% zero cuts in 2026, 28% hike odds at September). Geopolitical risk premium in oil from Trump Oman threats and Libya pipeline concerns. US recession odds priced at just 8% (inflation/fiscal-driven, not growth-driven). Consumer caution creeping in with credit cycle risk explicitly flagged by strategists.